ArticlePharmaceutics2024

Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors.

John C Panetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.